Congenital Myotonic Dystrophy
8 clinical trials · Condition
◉ Watch Congenital Myotonic Dystrophy
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy (NCT05004129) | AMO Pharma Limited | 2021-08-23 |
| Efficacy and Safety of Tideglusib in Congenital Myotonic Dystrophy (NCT03692312) | AMO Pharma Limited | 2021-03-03 |
| Trial Readiness and Endpoint Assessment in Congenital Myotonic Dystrophy (NCT03059264) | Virginia Commonwealth University | 2016-12-14 |
| Myotonic Dystrophy Family Registry (NCT02398786) | Myotonic Dystrophy Foundation | 2013-02-01 |
| Tideglusib: Expanded Access Use in Congenital Myotonic Dystrophy (NCT07119775) | AMO Pharma Limited |
Track Congenital Myotonic Dystrophy automatically
Every clearance here is in the API, with alerts when new ones post.